• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者微血管病变与大血管病变的分离

Dissociation of microangiopathy and macroangiopathy in patients with type 2 diabetes.

作者信息

Yamamoto M, Egusa G, Okubo M, Yamakido M

机构信息

Second Department of Internal Medicine, Hiroshima University School of Medicine, Japan.

出版信息

Diabetes Care. 1998 Sep;21(9):1451-4. doi: 10.2337/diacare.21.9.1451.

DOI:10.2337/diacare.21.9.1451
PMID:9727890
Abstract

OBJECTIVE

Although persistent hyperglycemia contributes greatly to the progression of diabetic micro- and macroangiopathy, microangiopathy progresses more rapidly than macroangiopathy in some type 2 diabetic patients, with the opposite being true in others. This study was conducted to identify factors responsible for such dissociation.

RESEARCH DESIGN AND METHODS

Patients with proliferative diabetic retinopathy and a carotid intima-media thickness (IMT) level < or =1.0 mm were classified as the microangiopathy group (MIG); those with an IMT level >1.1 mm and without retinopathy or with background retinopathy were assigned to the macroangiopathy group (MAG). Only middle-aged patients, 50-69 years old, were included in this study. There were 54 patients in the MIG and 68 patients in the MAG.

RESULTS

Patients in the MIG were significantly younger at the onset of diabetes, and those in the MAG had a significantly higher mean ratio of apoprotein (apo) B to apoAI. The percentage of patients with a family history of diabetes was significantly higher in the MIG. Maternal inheritance was common among these patients. Those with obesity, a family history of diabetes, and younger onset of hypertension were more common in the MAG. In the multiple logistic regression analyses, maternal inheritance and early onset of diabetes were independent risk factors for the acceleration of microangiopathy. A personal history of obesity and a family history of hypertension were independently related to the development of macroangiopathy.

CONCLUSIONS

Our results suggest that patients with early onset and maternal inheritance of diabetes may have a high risk for the progression of diabetic microangiopathy, while patients with hyperlipidemia, a history of obesity, and a family history of hypertension seem prone to the development of atherosclerosis.

摘要

目的

尽管持续性高血糖在糖尿病微血管和大血管病变进展中起很大作用,但在一些2型糖尿病患者中,微血管病变比大血管病变进展更快,而在另一些患者中情况则相反。本研究旨在确定导致这种分离的因素。

研究设计与方法

将患有增殖性糖尿病视网膜病变且颈动脉内膜中层厚度(IMT)水平≤1.0 mm的患者分类为微血管病变组(MIG);将IMT水平>1.1 mm且无视网膜病变或仅有背景性视网膜病变的患者分配到大血管病变组(MAG)。本研究仅纳入50至69岁的中年患者。MIG组有54例患者,MAG组有68例患者。

结果

MIG组患者糖尿病发病时明显更年轻,MAG组患者载脂蛋白(apo)B与apoAI的平均比值明显更高。MIG组中有糖尿病家族史的患者百分比明显更高。这些患者中母系遗传很常见。肥胖、有糖尿病家族史且高血压发病较早的患者在MAG组中更常见。在多因素逻辑回归分析中,母系遗传和糖尿病早发是微血管病变加速的独立危险因素。肥胖个人史和高血压家族史与大血管病变的发生独立相关。

结论

我们的结果表明,糖尿病早发且有母系遗传的患者可能发生糖尿病微血管病变的风险较高,而高脂血症、肥胖史和高血压家族史的患者似乎易患动脉粥样硬化。

相似文献

1
Dissociation of microangiopathy and macroangiopathy in patients with type 2 diabetes.2型糖尿病患者微血管病变与大血管病变的分离
Diabetes Care. 1998 Sep;21(9):1451-4. doi: 10.2337/diacare.21.9.1451.
2
Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.2型糖尿病视网膜病变与内膜中层厚度增加及内皮功能障碍有关。
Eur J Clin Invest. 2008 Dec;38(12):925-30. doi: 10.1111/j.1365-2362.2008.02051.x.
3
Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy.糖尿病微血管病变和大血管病变中可溶性黏附分子血清浓度的比较。
Diabet Med. 2002 Oct;19(10):822-6. doi: 10.1046/j.1464-5491.2002.00799.x.
4
Arterial stiffness is associated with diabetic retinopathy in Korean type 2 diabetic patients.在韩国2型糖尿病患者中,动脉僵硬度与糖尿病视网膜病变相关。
J Prev Med Public Health. 2011 Nov;44(6):260-6. doi: 10.3961/jpmph.2011.44.6.260.
5
Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus.1型糖尿病长期存活患者的颈动脉内膜中层复合体增厚
J Diabetes Complications. 2006 Sep-Oct;20(5):280-4. doi: 10.1016/j.jdiacomp.2005.07.012.
6
Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes.1型糖尿病患者的脑血管反应性、内膜中层厚度及肾病情况
Diabetes Care. 2009 May;32(5):878-82. doi: 10.2337/dc08-1805. Epub 2009 Feb 19.
7
Association between carotid plaque score and microvascular complications of type 2 diabetes.颈动脉斑块积分与 2 型糖尿病微血管并发症的关系。
Pol Arch Intern Med. 2017 Jun 30;127(6):418-422. doi: 10.20452/pamw.4024. Epub 2017 May 16.
8
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.血浆磷脂转运蛋白活性升高是2型糖尿病患者颈动脉内膜中层厚度的一个决定因素。
Diabetologia. 2006 Feb;49(2):398-404. doi: 10.1007/s00125-005-0088-0. Epub 2005 Dec 23.
9
Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.皮肤自发荧光与1型糖尿病患者的颈动脉内膜中层厚度、糖尿病微血管病变及长期代谢控制相关。波兹南前瞻性研究结果。
Microvasc Res. 2015 Mar;98:62-7. doi: 10.1016/j.mvr.2015.01.002. Epub 2015 Jan 10.
10
Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin.2型糖尿病中的颈动脉粥样硬化:内皮素-1、脂质过氧化物和前列环素的潜在作用。
Angiology. 2002 May-Jun;53(3):279-85. doi: 10.1177/000331970205300305.

引用本文的文献

1
The effect of chromium picolinate supplementation on the pancreas and macroangiopathy in type II diabetes mellitus rats.吡啶甲酸铬补充剂对II型糖尿病大鼠胰腺及大血管病变的影响。
J Diabetes Res. 2014;2014:717219. doi: 10.1155/2014/717219. Epub 2014 Jun 25.
2
Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function.甲状腺激素类似物3,5-二碘甲状腺丙酸可促进成年心肌的健康血管生成,且不依赖于甲状腺对心脏功能的影响。
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1551-7. doi: 10.1152/ajpheart.01293.2008. Epub 2009 Mar 13.